Recent developments in scientific research, technological innovation and advance on big data analysis open a new world of opportunities for clinical trials. Based on this new reality, the paradigm of IRPs that EU-PEARL is set to develop, will bring more efficiency to the design and implementation of clinical trials, potentially improving the speed of making new drugs available to patients.